Associated Papers
The Contribution of Genetic Modifiers to Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Cylwik D et al.
Cancers, 2026
Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia.
Fontecha MB et al.
Leukemia Research, 2025
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.
Bjørnslett M et al.
Bmc Cancer, 2012
Select a paper to view details